West Pharmaceutical Services Inc (WST)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 5.73 | 5.62 | 5.36 | 5.62 | 5.69 | 6.00 | 5.54 | 5.78 | 5.79 | 5.63 | 5.25 | 4.98 | 5.56 | 5.44 | 5.70 | 5.67 | 5.76 | 5.67 | 5.34 | 5.48 | |
| DSO | days | 63.75 | 64.93 | 68.15 | 64.96 | 64.13 | 60.84 | 65.85 | 63.15 | 63.00 | 64.86 | 69.55 | 73.25 | 65.67 | 67.06 | 64.04 | 64.38 | 63.34 | 64.39 | 68.32 | 66.55 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.73
= 63.75
The Days of Sales Outstanding (DSO) for West Pharmaceutical Services, Inc. have shown some fluctuations over the past eight quarters. In Q4 2023, the DSO was 63.35 days, which decreased compared to Q3 2023 (64.74 days) and Q2 2023 (68.06 days). This indicates that the company was able to collect its accounts receivable more efficiently in the most recent quarter.
Looking at previous quarters, Q4 2022 had a DSO of 64.15 days, slightly lower than the latest quarter. However, the DSO values in Q3 2022 (60.89 days) and Q1 2022 (65.86 days) were more favorable compared to Q4 2023, suggesting that the company's collection period was more efficient in those quarters.
Overall, the trend in DSO for West Pharmaceutical Services, Inc. has been relatively stable over the past year, with some minor fluctuations. It is important for the company to closely monitor and manage its accounts receivable collection process to ensure optimal cash flow and liquidity management.
Peer comparison
Dec 31, 2023